Results 141 to 150 of about 245,053 (402)
ABSTRACT Severe tricuspid regurgitation (TR) is associated with significant morbidity and mortality. Management of severe TR includes treatment of the underlying cause(s), medical therapy and less commonly surgical tricuspid valve repair. Newer transcatheter tricuspid valve repair devices show promise for those patients who remain symptomatic with ...
Mina M. Kerolos+4 more
wiley +1 more source
Imaging techniques in transcatheter aortic valve replacement
Robert A Quaife, Jennifer Dorosz, John C Messenger, Ernesto E Salcedo Division of Cardiology, University of Colorado, Aurora, CO, USA Abstract: Calcific aortic stenosis is now understood as a complex valvular degenerative process sharing many risk ...
Quaife RA+3 more
doaj
Transcatheter aortic valve implantation: The new option for high-risk patients with aortic stenosis [PDF]
Calcific aortic valve stenosis is the most common valvular heart disease in developed countries. Without surgery, the prognosis is extremely dismal. Therefore there is general agreement that surgical aortic valve replacement should be offered to patients
Grajek, Stefan+4 more
core +1 more source
Low Flow Low Gradient Severe Aortic Stenosis: Diagnosis and Treatment [PDF]
Approximately 40% of patients with aortic stenosis (AS) show discordant Doppler-echocardiographic parameters with aortic valve area (AVA)
Mohamad Ali, Faeez+2 more
core +1 more source
Comparative study of bicuspid vs. tricuspid aortic valve stenosis
Aims To examine differences and similarities in bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV) stenosis occurring during the same age and whether any differences impact outcomes following aortic valve replacement (AVR).
Geoffrey D. Huntley+13 more
semanticscholar +1 more source
ABSTRACT Background Little is known about the clinical and hemodynamic outcome of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR) for failed Trifecta surgical aortic bioprotheses. Aims We aimed to compare outcomes of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR into failed TrifectaTM vs.
Matthias Raschpichler+9 more
wiley +1 more source
Aortic stenosis has been shown to share the same risk factors as atherosclerosis which suggested a potential benefit from statins therapy. Fourteen studies which provided the effect of statins treatment on aortic stenosis (AS) were meta-analyzed ...
Ying Zhao+3 more
doaj
Aortic Valvuloplasty as Bridging for TAVI in High-Risk Patients with Heyde’s Syndrome: A Case Report
There is a frequent association between aortic valve stenosis and gastrointestinal bleeding, also known as Heyde’s syndrome. In these patients, the aortic valve replacement should be recommended as “gold standard.” In high-surgical-risk patients, the ...
Cosmo Godino+3 more
doaj +1 more source
Introduction and objectives: The Lotus Valve device (Boston Scientific) is a second-generation fully-retrievable and repositionable transcatheter aortic valve.
Daniele Gemma+14 more
doaj +1 more source
Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies
Aims The aim of this study was to examine the association of overall and abdominal obesity with aortic valve stenosis (AVS) incidence in two prospective cohorts.
S. Larsson+3 more
semanticscholar +1 more source